explore -WSS

explore

author：Wikipedia 2025-10-01 17:06:07 - browse：7911

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Wegovy cuts risk of cardiovascular events by 20%, study finds

explore

WSS

Millions may soon lose Medicaid when they don't have to

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Altering the blood type of lungs raises potential for universal organs for transplants

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Choosing scientific sides in the fight against Alzheimer's

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

entertainment

explore

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Timeline: Key moments in fight for gay rights

Supreme Court strikes down use of affirmative action

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Hollywood unions extend contract negotiations for actors

Sage's campaign to raise awareness of postpartum depression hits a nerve

Supreme Court strikes down use of affirmative action

‘The Bear’ and hospitality in hospitals

Walensky prepares to leave CDC — and Congress — behind

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

focus

The thinking behind the controversial eating disorder chatbot Tessa

Millions may soon lose Medicaid when they don't have to

More regulation could be coming for drug ads

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Wegovy cuts risk of cardiovascular events by 20%, study finds

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

hotspot

explore

Wikipedia

Wikipedia